Breaking News, Collaborations & Alliances

BioCorRx Enters Mfg. Partnership with IRISYS

For manufacturing of BICX102 naltrexone implant for treatment of opioid use disorder

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

BioCorRx, a developer and provider of solutions in the treatment of substance use disorders, has engaged IRISYS, LLC, a contract pharmaceutical product development and manufacturing services company, for the development and manufacturing of BICX102, a multi-month sustained release naltrexone implant. The company plans to conduct clinical trials and seek FDA approval for BICX102 as a treatment for opioid and alcohol use disorders.   “We look forward to partnering with such a reputable partner as ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters